NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: 3 out of 5

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.


Player Avatar HelpU2Build (50.28) Submitted: 2/16/2010 5:16:52 PM : Outperform Start Price: $8.40 NXTM Score: -2.36

Outstanding product potential for reducing medical cost and increasing quality of life results.

Featured Broker Partners